84
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Outcome of Adenoid Cystic Carcinoma of Head and Neck After Postoperative Intensity Modulation Radiotherapy: A Single Institution Study

, , , , , , & ORCID Icon show all
Pages 2411-2417 | Published online: 15 Mar 2021

References

  • Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al. Adenoid cystic carcinoma of the head and neck–an update. Oral Oncol. 2015;51:652–661. doi:10.1016/j.oraloncology.2015.04.00525943783
  • Amit M, Binenbaum Y, Sharma K, et al. Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study. Head Neck. 2014;36(7):998–1004. doi:10.1002/hed.2340523784851
  • Jang S, Patel PN, Kimple RJ, et al. Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck. Anticancer Res. 2017;37(6):3045–3052. doi:10.21873/anticanres.1165928551643
  • Li N, Xu L, Zhao H, et al. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the surveillance, epidemiology, and end results registry. Cancer. 2012;118(16):3945–3953. doi:10.1002/cncr.2674022179977
  • Suh Y-G, Lee CG, Kim H, et al. Treatment outcomes of intensity-modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting. Head Neck. 2016;38(Suppl 1):E207–E213. doi:10.1002/hed.2397125538027
  • Tao R, Ma D, Takiar V, et al. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck. 2016;38(Suppl 1):E580–E587. doi:10.1002/hed.2404425782700
  • Gay HA, Dyk P, Deasy JO, et al. Common Terminology Criteria for Adverse Events (CTCAE) v4.0 based hybrid patient and physician questionnaire for Head and Neck (HN) radiotherapy symptom reporting. Int J Radiat Oncol. 2011;81:S673. doi:10.1016/j.ijrobp.2011.06.929
  • Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26(2):154–162. doi:10.1002/hed.1038014762884
  • Takebayashi S, Shinohara S, Tamaki H, et al. Adenoid cystic carcinoma of the head and neck: a retrospective multicenter study. Acta Otolaryngol. 2018;138:73–79. doi:10.1080/00016489.2017.137132928899226
  • Ko JJ, Siever JE, Hao D, et al. Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre. Curr Oncol Tor Ont. 2016;23:26–33. doi:10.3747/co.23.2898
  • Khan AJ, DiGiovanna MP, Ross DA, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer. 2001;96:149–158. doi:10.1002/ijc.101311410883
  • Oplatek A, Ozer E, Agrawal A, et al. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection. Laryngoscope. 2010;120(1):65–70. doi:10.1002/lary.2068419877226
  • Zhang Q, Yang L, Yang A, et al. Clinical study on 88 cases of adenoid cystic carcinoma in nasal cavity and paranasal sinuses. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;44(4):311–314.19558839
  • van Weert S, Bloemena E, van der Waal I, et al. Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period. Oral Oncol. 2013;49(8):824–829. doi:10.1016/j.oraloncology.2013.05.00423751614
  • Choi Y, Kim S-B, Yoon DH, et al. Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neck. Laryngoscope. 2013;123(6):1430–1438. doi:10.1002/lary.2397623417869
  • Marcinow A, Ozer E, Teknos T, et al. Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: a single institutional experience at a tertiary care center. Head Neck. 2014;36(12):1705–1711. doi:10.1002/hed.2352324166847
  • Bjørndal K, Krogdahl A, Therkildsen MH, et al. Salivary adenoid cystic carcinoma in Denmark 1990–2005: outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol. 2015;51(12):1138–1142. doi:10.1016/j.oraloncology.2015.10.00226476712
  • Meyers M, Granger B, Herman P, et al. Head and neck adenoid cystic carcinoma: a prospective multicenter REFCOR study of 95 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133:13–17. doi:10.1016/j.anorl.2015.09.00926493113
  • Garden AS, Weber RS, Morrison WH, et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys. 1995;32(3):619–626. doi:10.1016/0360-3016(95)00122-F7790247
  • Dillon PM, Chakraborty S, Moskaluk CA, et al. Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials. Head Neck. 2016;38(4):620–627. doi:10.1002/hed.2392525487882
  • Subramaniam T, Lennon P, O’Neill JP. Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck. Ir J Med Sci. 2015;184(3):583–590. doi:10.1007/s11845-015-1298-125894281
  • Papaspyrou G, Hoch S, Rinaldo A, et al. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review. Head Neck. 2011;33:905–911. doi:10.1002/hed.2145820652885
  • Veit JA, Heine D, Thierauf J, et al. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck. Head Neck. 2016;38:1008–1016. doi:10.1002/hed.2440326874246